Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.9 - $1.06 $24,030 - $28,302
26,700 New
26,700 $25,000
Q2 2023

Aug 14, 2023

BUY
$1.1 - $1.54 $3,219 - $4,507
2,927 Added 4.29%
71,146 $86,000
Q1 2023

May 15, 2023

BUY
$1.19 - $2.09 $2,313 - $4,062
1,944 Added 2.93%
68,219 $85,000
Q4 2022

Feb 14, 2023

BUY
$1.67 - $2.35 $27,244 - $38,337
16,314 Added 32.65%
66,275 $123,000
Q3 2022

Nov 14, 2022

BUY
$1.81 - $2.76 $4,253 - $6,485
2,350 Added 4.94%
49,961 $96,000
Q2 2022

Aug 15, 2022

BUY
$1.34 - $5.34 $31,102 - $123,946
23,211 Added 95.13%
47,611 $99,000
Q1 2022

May 16, 2022

SELL
$4.58 - $6.8 $1,465 - $2,176
-320 Reduced 1.29%
24,400 $112,000
Q4 2021

Feb 14, 2022

SELL
$5.23 - $7.18 $40,846 - $56,075
-7,810 Reduced 24.01%
24,720 $159,000
Q3 2021

Nov 15, 2021

BUY
$5.94 - $8.75 $3,148 - $4,637
530 Added 1.66%
32,530 $201,000
Q2 2021

Aug 16, 2021

BUY
$7.54 - $9.79 $241,280 - $313,280
32,000 New
32,000 $256,000
Q1 2021

May 17, 2021

SELL
$4.76 - $11.25 $326,883 - $772,571
-68,673 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$2.43 - $5.42 $100,378 - $223,889
-41,308 Reduced 37.56%
68,673 $331,000
Q3 2020

Nov 16, 2020

BUY
$2.3 - $3.72 $15,596 - $25,225
6,781 Added 6.57%
109,981 $274,000
Q2 2020

Aug 14, 2020

BUY
$1.33 - $3.63 $137,256 - $374,616
103,200 New
103,200 $320,000
Q1 2020

May 15, 2020

SELL
$1.27 - $2.33 $101,907 - $186,963
-80,242 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.3 - $2.72 $13,322 - $27,874
10,248 Added 14.64%
80,242 $163,000
Q3 2019

Nov 14, 2019

BUY
$1.93 - $4.21 $135,088 - $294,674
69,994 New
69,994 $165,000
Q1 2019

May 15, 2019

SELL
$1.79 - $3.12 $106,449 - $185,543
-59,469 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.24 - $3.9 $10,080 - $17,550
-4,500 Reduced 7.03%
59,469 $153,000
Q3 2018

Nov 14, 2018

SELL
$3.58 - $4.9 $23,556 - $32,242
-6,580 Reduced 9.33%
63,969 $249,000
Q2 2018

Aug 14, 2018

SELL
$4.43 - $5.14 $14,707 - $17,064
-3,320 Reduced 4.49%
70,549 $336,000
Q1 2018

May 15, 2018

BUY
$4.65 - $5.9 $134,231 - $170,315
28,867 Added 64.15%
73,869 $384,000
Q4 2017

Feb 12, 2018

BUY
$4.32 - $5.52 $61,905 - $79,101
14,330 Added 46.72%
45,002 $208,000
Q3 2017

Nov 07, 2017

BUY
$4.35 - $5.25 $133,423 - $161,028
30,672
30,672 $161,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.